Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
4(36%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_3
6
55%
Ph phase_1
4
36%
Ph phase_2
1
9%

Phase Distribution

4

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
4(36.4%)
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
6(54.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

11

all time

Status Distribution
Active(6)
Completed(5)

Detailed Status

Completed5
Not yet recruiting2
Recruiting2
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
11
Active
4
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (36.4%)
Phase 21 (9.1%)
Phase 36 (54.5%)

Trials by Status

not_yet_recruiting218%
completed545%
recruiting218%
active_not_recruiting218%

Recent Activity

4 active trials
Showing 5 of 11
active_not_recruitingphase_3

A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

NCT05567796
not_yet_recruitingphase_1

A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or Obesity

NCT07557953
not_yet_recruitingphase_1

Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)

NCT07527195
recruitingphase_3

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

NCT07253285
completedphase_1

Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes

NCT06403761
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT05567796Phase 3

A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

Active Not Recruiting
NCT07557953Phase 1

A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or Obesity

Not Yet Recruiting
NCT07527195Phase 1

Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)

Not Yet Recruiting
NCT07253285Phase 3

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Recruiting
NCT06403761Phase 1

Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes

Completed
NCT05394519Phase 3

A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight

Completed
NCT06065540Phase 3

A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

Completed
NCT06780449Phase 3

A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity

Active Not Recruiting
NCT05996848Phase 3

A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight

Completed
NCT04982575Phase 2

Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes

Completed
NCT07010432Phase 1

The Role of the Amylin Analogue Cagrilintide in Bone Metabolism

Recruiting

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11